Top 19 eTheRNA immunotherapies investors
The most complete profiles first. Showing 19 of 19.
Annie MitsakVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Verified email available
Debbie LinVerified
Venture Capital, Corporate Venture Capital, Investor · United States
SeedHealth CareHospitalsWellnessWomen FoundedPortfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 36 more
Verified email available
Johannes ZanzingerVerified
Venture Capital, Corporate Venture Capital, Investor · Germany
Series BSeries AHealth CareHospitalsWellnessWomen FoundedPortfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 36 more
Verified email available
Martin HeideckerVerified
Venture Capital, Corporate Venture Capital, Private Equity Firm · United States
SeedHealth CareHospitalsWellnessWomen FoundedPortfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 36 more
Verified email available
AnneVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Verified email available
Detlev MennerichVerified
Corporate Venture Capital · Germany
Health CareHospitalsWellnessWomen FoundedPortfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 35 more
Verified email available
Paulina HillVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Verified email available
Drew Burdon
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareLife ScienceMobileManufacturingPortfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more
Contact details available
Francesco Draetta
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Contact details available
Katie Kerfoot
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Contact details available
Martijn Kleijwegt
Venture Capital, Private Equity Firm, Investor · Netherlands
Series BHealth CareLife ScienceMobileManufacturingPortfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more
Contact details available
Michelle Doig
Venture Capital, Investor · Canada
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Contact details available
Oliver Reuss
Venture Capital, Corporate Venture Capital, Investor · Germany
Series BSeries AHealth CareHospitalsWellnessWomen FoundedPortfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 35 more
Contact details available
Rudy Dekeyser
Venture Capital, Private Equity Firm, Investor · Belgium
Series BHealth CareHospitalsLife ScienceMobilePortfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more
Contact details available
Sebastian Kreuz
Venture Capital, Corporate Venture Capital, Investor · Germany
Series BSeries AHealth CareHospitalsWellnessWomen FoundedPortfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 35 more
Contact details available
Vincent Brichard
Private Equity Firm, Investor · Netherlands
SeedHealth CareLife ScienceMobileManufacturingPortfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more
Contact details available
Alexandra Tolia
Private Equity Firm · Belgium
Health CareGeneticsLife ScienceDiabetesPortfolio: Ona Therapeutics, eTheRNA immunotherapies, Indigo Diabetes, Confo Therapeutics and 8 more
Contact details available
Ilka Wicke Dr.
Corporate Venture Capital · Germany
Health CareHospitalsWellnessWomen FoundedPortfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 35 more
Contact details available
Merijn Klaassen
Private Equity Firm · Netherlands
Health CareLife ScienceMobileManufacturingPortfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
- Promethera Biosciences13
- Immunic12
- Cardior Pharmaceuticals12
- ImCheck Therapeutics12
- FoRx Therapeutics11
- Kuros Biosciences11
- Aelin Therapeutics8
- STAT-Dx7
- Topas Therapeutics7
- Brainomix7
- Wellth7
Frequently asked questions
How many eTheRNA immunotherapies investors are on Angel Roster?
Angel Roster lists 19 eTheRNA immunotherapies investors. 7 of them (37%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (14), Private Equity Firms (7) and Corporate Venture Capital Firms (7). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do eTheRNA immunotherapies investors invest in?
Among those that list a stage, the most common are Seed (7), Series B (6) and Series A (3).
Where are eTheRNA immunotherapies investors based?
Most are based in the United States (7), Germany (5) and the Netherlands (3).
Which companies have eTheRNA immunotherapies investors backed?
The most-backed portfolio companies among them are Promethera Biosciences (13), Immunic (12), Cardior Pharmaceuticals (12), ImCheck Therapeutics (12) and FoRx Therapeutics (11).
How do I contact eTheRNA immunotherapies investors?
Create a free Angel Roster account to search and filter all 19, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.